ATLANTA--(BUSINESS WIRE)--Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced results for the fourth quarter and full year ended December 31, 2025. “Mirion concluded another successful year, highlighted by record orders, strong tailwinds from key strategic end-markets, and a broadening nuclear power portfolio,” commented Mirion's Chairman.